Medpace Holdings, Inc. (MEDP)
Automate Your Wheel Strategy on MEDP
With Tiblio's Option Bot, you can configure your own wheel strategy including MEDP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MEDP
- Rev/Share 81.2308
- Book/Share 10.114
- PB 59.367
- Debt/Equity 0.4903
- CurrentRatio 0.5742
- ROIC 0.8556
- MktCap 16913314008.0
- FreeCF/Share 24.2343
- PFCF 24.0385
- PE 40.2592
- Debt/Assets 0.0821
- DivYield 0
- ROE 0.9188
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | MEDP | Barclays | Equal Weight | Underweight | -- | $425 | Oct. 2, 2025 |
| Downgrade | MEDP | Rothschild & Co Redburn | Buy | Neutral | -- | $474 | Sept. 3, 2025 |
| Downgrade | MEDP | UBS | Neutral | Sell | -- | $305 | July 29, 2025 |
| Downgrade | MEDP | TD Cowen | Hold | Sell | -- | $366 | July 23, 2025 |
| Initiation | MEDP | Barclays | -- | Equal Weight | -- | $300 | June 24, 2025 |
| Downgrade | MEDP | William Blair | Outperform | Market Perform | -- | -- | April 22, 2025 |
| Downgrade | MEDP | TD Cowen | Buy | Hold | -- | $328 | April 14, 2025 |
| Initiation | MEDP | Leerink Partners | -- | Market Perform | -- | $330 | March 24, 2025 |
| Downgrade | MEDP | Robert W. Baird | Outperform | Neutral | $413 | $349 | Oct. 23, 2024 |
| Initiation | MEDP | Redburn Atlantic | -- | Buy | -- | -- | Oct. 14, 2024 |
News
BTSG vs. MEDP: Which Stock Is the Better Value Option?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Medpace Holdings, Inc. (MEDP) Q3 2025 Earnings Call Transcript
Published: October 23, 2025 by: Seeking Alpha
Sentiment: Neutral
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q3 2025 Earnings Call October 23, 2025 9:00 AM EDT Company Participants Lauren Morris - Associate Director of Investors Relations August Troendle - Chairman & CEO Jesse Geiger - President Kevin Brady - CFO & Treasurer Conference Call Participants Charles Rhyee - TD Cowen, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Michael Cherny - Leerink Partners LLC, Research Division David Windley - Jefferies LLC, Research Division Max Smock - William Blair & Company L.L.C., Research Division Jailendra Singh - Truist Securities, Inc., Research Division Daniel Leonard - UBS Investment Bank, Research …
Read More
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
Published: October 23, 2025 by: Benzinga
Sentiment: Positive
Medpace Holdings Inc. (NASDAQ:MEDP) is trading higher on Thursday after the company released third-quarter earnings.
Read More
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Medpace (MEDP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
Read More
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Published: October 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.
Read More
Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)
Published: September 17, 2025 by: Seeking Alpha
Sentiment: Positive
For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value for its investors. In the first half of 2025, the company had a capex-to-revenues ratio of 1.39%, which contributed to the company's high net profit margin.
Read More
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Non-tech Nasdaq standouts like HAS, HOOD, IBKR, CELH and MEDP are fueling 2025's index surge.
Read More
COR vs. MEDP: Which Stock Is the Better Value Option?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both Cencora (COR) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Read More
Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Should You Buy Medpace (MEDP) After Golden Cross?
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
After reaching an important support level, Medpace Holdings, Inc. (MEDP) could be a good stock pick from a technical perspective. MEDP recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Read More
What Makes Medpace (MEDP) a New Strong Buy Stock
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
Best Momentum Stocks to Buy for July 28th
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CALX, MEDP and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2025.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Medpace Holdings, Inc. (MEDP) Q2 2025 Earnings Call Transcript
Published: July 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants August James Troendle - Chairman & CEO Jesse J. Geiger - President Kevin M.
Read More
Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase
Published: July 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase
Read More
OGN or MEDP: Which Is the Better Value Stock Right Now?
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either Organon (OGN) or Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: July 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
OGN vs. MEDP: Which Stock Is the Better Value Option?
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medpace (MEDP) closed the most recent trading day at $326.03, moving +1.55% from the previous trading session.
Read More
CON or MEDP: Which Is the Better Value Stock Right Now?
Published: June 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Read More
CON vs. MEDP: Which Stock Is the Better Value Option?
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Read More
CON or MEDP: Which Is the Better Value Stock Right Now?
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Analysts Estimate Medpace (MEDP) to Report a Decline in Earnings: What to Look Out for
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Negative
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
CON vs. MEDP: Which Stock Is the Better Value Option?
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
About Medpace Holdings, Inc. (MEDP)
- IPO Date 2016-08-11
- Website https://www.medpace.com
- Industry Medical - Diagnostics & Research
- CEO August James Troendle
- Employees 5900